Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Summary of Significant Accounting Policies [Abstract]

Schedule of Cash Balances by Geographic Area

At December 31, 2025 and 2024, the Company’s cash balances by geographic area were as follows:

Country:		December 31, 2025								December 31, 2024
United States		$	108,599				99.5	%		$	2,646,395				99.6	%
China			492				0.5	%			11,787				0.4	%
Total cash		$	109,091				100.0	%		$	2,658,182				100.0	%

Schedule of Derivative Liability Measured at Fair Value

The table below reflects the activity of derivative liability measured at fair value for the years ended December 31, 2025 and 2024:

		Significant Unobservable Inputs (Level 3)
Balance of derivative liability as of January 1, 2024		$	24,796
Initial fair value of derivative liability attributable to warrants issuance with March and June 2024 fund raises			479,468
Reclassification of additional paid-in capital upon conversion			(2,354	)
Gain from change in the fair value of derivative liability			(374,365	)
Balance of derivative liability as of December 31, 2024			127,545
Initial fair value of derivative liability attributable to Second Warrant issuance with June 2024 fund raise (See Note 11)			621,353
Gain from change in the fair value of derivative liability			(538,213	)
Reclassification of additional paid-in capital upon conversion			(176,529	)
Balance of derivative liability as of December 31, 2025		$	34,156

Schedule of Securities that were Excluded from the Diluted Per Share

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive:

		Years Ended December 31,
		2025				2024
Options to purchase common stock			41,169				52,479
Warrants to purchase common stock			95,746				182,996
Series A convertible preferred stock ^(*)			-				60,000
Series B convertible preferred stock ^(**)			-				194,004
Series C convertible preferred stock ^(***)			1,576,763				1,452,282
Series D convertible preferred stock (****)			2,074,689				-
Series E convertible preferred stock (*****)			13,000,000				-
Convertible notes and related accrued interest (******)			788,283				227,269
Potentially dilutive securities			17,576,650				2,169,030

(*)	Assumed the Series A convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $150.00 per share.

(**)	Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.

(***)

Assumed the Series C convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.

(****)

Assumed the Series D convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.

(*****)

Assumed the Series E convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $1.50 per share.

(******)

Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $1.00 per share for the years ended December 31, 2025. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $11.25 per share for the year ended December 31, 2024.